Business Standard

Saturday, December 21, 2024 | 07:33 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Dr Reddy's Labs gains for second straight day on Covid vaccine deal

Upon regulatory approval in India, RDIF shall supply to Dr. Reddy's 100 million doses of the vaccine

reddy, dr reddy's
Premium

SI Reporter New Delhi
Shares of Dr Reddy's Laboratories extended their gains to the second straight day, up as much as 2.4 per cent to Rs 4,748 on the BSE on Thursday. The stock had risen 4.4 per cent in the last trading session after the firm and Russia's sovereign wealth fund, Russian Direct Investment Fund (RDIF), agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.

Upon regulatory approval in India, RDIF shall supply to Dr. Reddy's 100 million doses of the vaccine, Dr Reddys said in a release on Wednesday. The Sputnik V vaccine, which is based on

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in